 Y-mAbs Therapeutics, Inc. NASDAQ:YMAB Q2 2022 Results Conference Call August 9, 2022 9:00 AM ET Company Participants Thomas Gad - Founder, Interim CEO and President Bo Kruse - CFO Sue Smith - Chief Commercial Officer Vignesh Rajah - Chief Medical Officer Conference Call Participants Alec Stranahan - Bank of America Robert Burns - HC Wainwright Charles Zhu - Guggenheim Joseph Thome - Cowen Company Tessa Romero - JP Morgan Mike Ulz - Morgan Stanley William Maughan - Canaccord Genuity Operator Good morning and welcome to the Y-mAbs Therapeutics, Inc., Earnings Conference Call for the Second Quarter 2022. Todays conference is being recorded. 